blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2400981

EP2400981 - HUMANIZED PLATELET ACTIVATING FACTOR ANTIBODY DESIGN USING ANTI-LIPID ANTIBODY TEMPLATES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.01.2014
Database last updated on 08.10.2024
Most recent event   Tooltip17.01.2014Application deemed to be withdrawnpublished on 19.02.2014  [2014/08]
Applicant(s)For all designated states
Lpath, Inc.
4025 Sorrento Valley Blvd.
San Diego, CA 92121 / US
[2013/10]
Former [2012/01]For all designated states
Lpath, Inc.
6335 Ferris Square, Suite A
San Diego, CA 92121-3249 / US
Inventor(s)01 / SABBADINI, Roger, A.
12509 Del Sol Road
Lakeside, CA 92040 / US
02 / WOJCIAK, Jonathan, Michael
221 North Willowspring Drive
Encinitas, CA 92024 / US
 [2012/01]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2012/01]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date10746551.026.02.2010
WO2010US00571
Priority number, dateUS20090155897P26.02.2009         Original published format: US 155897 P
US20090155895P26.02.2009         Original published format: US 155895 P
US2009063178404.12.2009         Original published format: US 631784
[2012/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010098863
Date:02.09.2010
Language:EN
[2010/35]
Type: A1 Application with search report 
No.:EP2400981
Date:04.01.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 02.09.2010 takes the place of the publication of the European patent application.
[2012/01]
Search report(s)International search report - published on:US02.09.2010
(Supplementary) European search report - dispatched on:EP25.01.2013
ClassificationIPC:A61K39/00, C12P21/08, C07K16/18, C07K16/44
[2013/08]
CPC:
C07K16/44 (EP,US); G16B15/30 (EP,US); C07K16/18 (EP,US);
G16B15/00 (EP,US); A61K2039/505 (EP,US); A61K2039/507 (EP,US);
C07K2299/00 (EP,US); C07K2317/24 (EP,US); C07K2317/55 (EP,US);
C07K2317/56 (EP,US); C07K2317/565 (EP,US); C07K2317/567 (EP,US);
C07K2317/92 (EP,US) (-)
Former IPC [2012/01]A61K39/00, C12P21/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/01]
Extension statesAL26.09.2011
BA26.09.2011
RS26.09.2011
TitleGerman:DESGIN FÜR HUMANISIERTEN THROMBOZYTENAKTIVIERUNGSFAKTOR-ANTIKÖRPER MITTELS ANTI-LIPID-ANTIKÖRPER-TEMPLATES[2012/01]
English:HUMANIZED PLATELET ACTIVATING FACTOR ANTIBODY DESIGN USING ANTI-LIPID ANTIBODY TEMPLATES[2012/01]
French:CONCEPTION D'ANTICORPS HUMANISÉ ANTI-FACTEUR D'ACTIVATION PLAQUETTAIRE À L'AIDE DE MODÈLES D'ANTICORPS ANTI-LIPIDE[2012/01]
Entry into regional phase26.09.2011National basic fee paid 
26.09.2011Search fee paid 
26.09.2011Designation fee(s) paid 
26.09.2011Examination fee paid 
Examination procedure26.09.2011Amendment by applicant (claims and/or description)
26.09.2011Examination requested  [2012/01]
23.08.2013Application deemed to be withdrawn, date of legal effect  [2014/08]
30.09.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/08]
Fees paidRenewal fee
23.02.2012Renewal fee patent year 03
25.02.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO8705904  (UNIV SYDNEY [AU], et al) [I] 1-5* examples 5-7 *;
 [I]  - MACPHERSON J L ET AL, PRODUCTION AND CHARACTERIZATION OF ANTIBODIES TO PLATELET-ACTIVATING FACTOR, JOURNAL OF LIPID MEDIATORS, VOL. 5, NR. 1, PAGE(S) 49-59, (1992), ISSN 0921-8319, XP002689910 [I] 1-5 * par. 3.3 *
 [I]  - KOOYMAN FRANS N J ET AL, "Antibodies elicited by the bovine lungworm, Dictyocaulus viviparus, cross-react with platelet-activating factor", INFECTION AND IMMUNITY, (200709), vol. 75, no. 9, ISSN 0019-9567, pages 4456 - 4462, XP002689911 [I] 1-5 * abstract *

DOI:   http://dx.doi.org/10.1128/IAI.00633-07
International search[X]US5061626  (BALDO BRIAN A [AU], et al);
 [X]US2008213274  (SABBADINI ROGER A [US], et al);
 [Y]  - SODERLIND ET AL., "Recombining germline-derived CDR sequences for creating diverse single- framework antibody libraries.", NAT BIOTECHNOL., (2000), vol. 18, no. 8, pages 852 - 856, XP009010618

DOI:   http://dx.doi.org/10.1038/78458
 [Y]  - BARDERAS ET AL., "Affinity maturation of antibodies assisted by in silico modeling.", PROC NATL ACAD SCI U S A., (2008), vol. 105, no. 26, pages 9029 - 9034, XP002592575

DOI:   http://dx.doi.org/10.1073/PNAS.0801221105
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.